Clinical Trial Update: THRIVE: Culturally AdapTed Harm Reduction Intervention [NA]

View source ↗

Summary

This is a completed clinical trial update for THRIVE, a culturally adapted harm reduction intervention. It targets opioid use disorder and stimulant use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Stimulant Use Disorder

Snippet

Sponsor: Brittany Miller-Roenigk | Conditions: Opioid Use, Stimulant Use | NA | Status: COMPLETED